Apogee Therapeutics, Inc.
APGE
$39.94
$1.614.20%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.66% | 24.40% | 440.68% | 477.50% | 160.36% |
| Total Receivables | 286.90% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 50.98% | 51.44% | 80.19% | 984.62% | 1,507.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -71.93% | -22.25% | 414.18% | -- |
| Total Current Assets | 32.96% | 25.34% | 421.82% | 477.82% | 162.02% |
|
|
|||||
| Total Current Assets | 32.96% | 25.34% | 421.82% | 477.82% | 162.02% |
| Net Property, Plant & Equipment | 413.65% | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24.19% | -- | -- | -- | -- |
| Total Assets | 87.83% | 82.05% | 512.75% | 479.97% | 163.99% |
|
|
|||||
| Total Accounts Payable | -50.02% | 83.44% | -50.42% | 345.80% | 412.68% |
| Total Accrued Expenses | 40.09% | 72.37% | 169.18% | 57.47% | 81.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 193.73% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 38.92% | 89.84% | 39.75% | 92.52% | 105.99% |
|
|
|||||
| Total Current Liabilities | 38.92% | 89.84% | 39.75% | 92.52% | 105.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 821.44% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 72.90% | 143.82% | 53.38% | 98.15% | 115.34% |
|
|
|||||
| Common Stock & APIC | 103.00% | 93.52% | 42,708.00% | 42,437.49% | 22,261.35% |
| Retained Earnings | -147.16% | -159.36% | -166.42% | -197.96% | -211.10% |
| Treasury Stock & Other | 178.12% | 2,322.22% | -106.38% | -105.18% | -84.64% |
| Total Common Equity | 88.67% | 79.45% | 1,301.02% | 1,818.32% | 1,173.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 88.67% | 79.45% | 1,301.02% | 1,818.32% | 1,173.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 88.67% | 79.45% | 584.32% | 512.64% | 167.40% |
|
|
|||||
